A Phase I, Single-dose Study with SB206 in Healthy Japanese Adults

Tsubouchi Ichiro0 个研究点目标入组 20 人开始时间: 2022年5月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Healthy Japanese adult males aged 20 to 40 years at the time of obtaining written informed consent
•2. Subjects with a body mass index (BMI) of 18.5 to 25.0 at screening
•3. Subjects who are considered by the investigator or subinvestigator as acceptable for inclusion in the study as judged from the results of observation and examination upon screening and hospitalization
•4. Subjects who received full explanations regarding the objective of the study, details of the study and the study drug and provided voluntary written informed consent

•1. Subjects with a history of drug allergy
•2. Subjects with a history of food allergy
•3. Subjects with a history of contact dermatitis, such as adhesive tape dermatitis, or mechanical urticaria
•4. Subjects considered ineligible for the study by the investigator or subinvestigator

发起方

Tsubouchi Ichiro